Preclinical toxicology from a top preclinical CRO in Eastern Europe.

We are an independent CRO operating out of the United States that offers pre-clinical medicine trials in top-notch, GLP-certified research facilities in Kiev, Ukraine. Our research facilities are supported by the Ukrainian National Academy of Medical Sciences and Ministry of Health and offer support for for-profit development of new drug discoveries as part of their core purpose. Our business was founded to provide the top-notch, inexpensive services of these laboratories to emerging bio-technology companies in the United States and Europe, thereby offering a smart option for advancing development programs quickly and at much lower cost than other commercial CROs. We provide a wide range of preclinical testing including drug safety, chronic and acute toxicity, pharmacological screening, bioavailability, bioequivalence, and complete in vitro and in vivo screening for anticancer activity.

Our preclinical Contract Research Organization is able to price preclinical testing far below other Contract Research Organizations since we maintain a very low overhead in the United States and perform all trials in Kiev where labor and lab costs are much lower. Our team in the U.S. is comprised of only of the company principals who work directly with clients; we have no marketing expenses other than our website, and no main offices, supporting staff or other overhead to inflate costs. We have much lower study conduct costs in Kiev due to much lower labor rates and are able to offer our best rates for longer and more complex preclinical studies where labor is the greatest portion of the overall price. Since we utilize the same reliable international suppliers for lab animals, reagents and lab materials as other Contract Research Organizations, we don’t have any cost advantage on these materials and thus less overall cost savings for very short-term preclinical studies. However, regardless of your trial protocol and length, our goal is to give our clients the best possible value for their money.

Tags: , , , , , ,

Related posts